Related Experiment Video
Updated: Sep 14, 2025

03:05
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
1.2K
Predictive Factors of Malignancy in Cervical Paragangliomas: A Retrospective Study
Garance Haw1, Maxime Fieux2,3,4, Anthime Flaus5,6
1Hospices Civils de Lyon, Hôpital de la Croix Rousse, Service d'ORL et de Chirurgie Cervico-Faciale, Lyon, France.
Head & Neck
|July 19, 2025
Summary
Identifying metastatic cervical paragangliomas (cPG) early is crucial. This study found seven key risk factors, including tumor necrosis and invasion, to predict aggressive cPG and guide treatment.
Area of Science:
- Oncology
- Radiology
- Pathology
Background:
- Metastatic cervical paragangliomas (cPG) pose a significant clinical challenge due to a lack of early predictive factors.
- Accurate prediction of metastatic potential is essential for timely intervention and improved patient outcomes.
Purpose of the Study:
- To identify early predictive factors for metastatic cervical paragangliomas (cPG).
- To establish criteria for identifying aggressive cPG to optimize therapeutic strategies.
Main Methods:
- A multicenter retrospective study analyzed data from patients with cervical paragangliomas (cPG).
- Metastatic cPG were defined by histological evidence of lymph node or distant metastases.
- Logistic regression was employed to identify predictive factors based on clinical, radiological, intraoperative, histological, and mutational data.
Main Results:
- Seven novel risk factors for metastatic cPG were identified in 86 cPGs from 67 patients (12.8% metastatic).
- Morphological imaging (MRI/CT) revealed necrosis, extracapsular extension, and pathological lymph nodes as indicators.
- Functional imaging (FDG-PET-CT) showed heterogeneous tumor uptake and abnormal lymph node uptake.
- Surgical findings of adjacent tissue invasion and sacrifice of noble structures were significant predictors.
Conclusions:
- The identified risk factors, including imaging and surgical findings, can aid in the prompt identification of aggressive cPG.
- Combining these factors allows for early risk stratification and adaptation of treatment plans for cPG.
Related Concept Videos
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer
49.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.6K

